-
Experts to review latest findings on GIP signaling
Makoto Fukuda, PhD, and Tune H. Pers, PhD, will discuss GIP signaling in the brain and its effects on food intake and energy balance at this year’s ADA Diabetes Symposium.
-
Session will celebrate life-changing century of insulin discovery, advances
In 1921, the discovery of insulin transformed type 1 diabetes from a death sentence. Peter Arvan, MD, PhD, and Michael A. Weiss, MD, PhD, MBA, will explore the ramifications of this critical inflection point in medicine.
-
Mental health is key to comprehensive care at all ages
Maisa N. Feghali, MD, Randi Streisand, PhD, CDCES, and Jessica Pierce, PhD, will outline how the strategies providers use to promote positive mental health for their patients living with diabetes must evolve as their patients mature.
-
Pandemic-related changes to diabetes care during pregnancy may be here to stay
David McIntyre, MD, FRACP, and Noelia M. Zork, MD, will discuss the perfect storm created by the confluence of COVID-19, diabetes, and pregnancy—from new approaches to the diagnosis and management of diabetes in pregnancy to an expansion of telemedicine.
-
DARE-19 results provide insight into SGLT2 inhibitor use in patients with type 2 diabetes and COVID-19
DARE-19 Principal Investigator Mikhail Kosiborod, MD, will provide the first look at a subgroup analysis of type 2 diabetes patients who are at higher risk for developing serious complications from COVID-19.
-
Frontline professionals will discuss interplay between COVID-19 and diabetes
The diabetes community moved quickly to understand and counter the deadly dynamics of COVID-19 and hyperglycemia. Alberto Coppelli, MD, and Francisco J. Pasquel, MD, MPH, provide a view from the frontlines.
-
Experts will explain how viruses, including COVID-19, affect pediatric diabetes risk
“The relationship between viruses, genetic background, and the immune system are all involved in this autoimmune process that leads to disease,” explains epidemiologist Kendra Vehik, PhD, MPH.
-
Questions of readiness feed precision nutrition debate
Paul W. Franks, PhD, and Kevin D. Hall, PhD, will present opposing viewpoints about whether the hype about precision nutrition outweighs the science during a debate on the final day of the Scientific Sessions.
-
Long-standing barriers complicate patient care despite effective DKD treatment options
Maryam Afkarian, MD, PhD, will explore some of the challenges to the practical application of tools to manage diabetes and kidney disease.
-
Experts to weigh starting SGLT2 inhibitors and GLP-1 receptor agonists in the hospital
Jennifer Green, MD, will discuss some of the factors that may give clinicians second thoughts about initiating the two drug classes.